Fundz

Oxford Endovascular raises £8 million for human trials of origami brain stent

PRIVATEMay 19, 2024

Amount Raised

£8 Million

Round Type

Series A

OxfordManufacturingBiotechnologySolar

Investors

Vulpes Investment ManagementOxford Science EnterprisesOxford UniversityNorcliffe CapitalParkwalk Advisors

Description

Oxford Endovascular, a medical technology business, has raised £8 million to start human trials for its folding concept that treats brain haemorrhages by inserting tubes inside the brain’s blood vessels to heal weak spots. The investment, led by Parkwalk Advisors, Norcliffe Capital, Oxford University, Oxford Science Enterprises, and Vulpes Investment Management, aims to fund a test programme.

Quick answer

Oxford Endovascular raised £8 Million in a Series A round, dated May 19, 2024. Investors: Vulpes Investment Management, Oxford Science Enterprises, Oxford University, Norcliffe Capital and Parkwalk Advisors. Oxford Endovascular is based in Oxford, England, United Kingdom.

How much did Oxford Endovascular raise?
Oxford Endovascular raised £8 Million in a Series A round on May 19, 2024.
Who invested in Oxford Endovascular?
Vulpes Investment Management, Oxford Science Enterprises, Oxford University, Norcliffe Capital and Parkwalk Advisors are named as investors in this round.
What does Oxford Endovascular do?
Oxford Endovascular is a spin out from Oxford University developing technology to prevent brain haemorrhage.
Where is Oxford Endovascular based and how big is it?
Oxford Endovascular is based in Oxford, England, United Kingdom.
Who are the decision-makers at Oxford Endovascular?
Fundz holds 1 contact at Oxford Endovascular. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Oxford Endovascular, and when

A new round usually means Oxford Endovascular is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Oxford Endovascular raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oxford Endovascular, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oxford Endovascular. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oxford Endovascular

Location

Oxford, England, United Kingdom

About

Oxford Endovascular is a spin out from Oxford University developing technology to prevent brain haemorrhage. OxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. OxiFlow™️ is a unique design that places more accurately and safely than existing products, reducing risk of complications and conforms to blood vessel shapes making more patients treatable. Patented in Europe, US, China & Japan.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oxford Endovascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Oxford Endovascular's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Oxford Endovascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.